Stattic Enhances Radiosensitivity and Reduces Radio-Induced Migration and Invasion in HCC Cell Lines through an Apoptosis Pathway

IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study

(2015) Jung-Ta Kao et al.   BMC GASTROENTEROLOGY

Systemic Therapy of Hepatocellular Carcinoma

(2015) Aparna Kalyan et al.   Clinics in Liver Disease

STAT3 regulates the migration and invasion of a stem-like subpopulation through microRNA-21 and multiple targets in hepatocellular carcinoma

(2015) NING ZHANG et al.   ONCOLOGY REPORTS

FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling

(2014) Zhaoyang Lu et al.   BMC CANCER

STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinoma

(2014) Qu Zhang et al.   TUMOR BIOLOGY

STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapyin vitroandin vivo

(2013) Melanie Spitzner et al.   INTERNATIONAL JOURNAL OF CANCER

Stat3 Inhibitor Stattic Exhibits Potent Antitumor Activity and Induces Chemo- and Radio-Sensitivity in Nasopharyngeal Carcinoma

(2013) Yunbao Pan et al.   PLoS One

Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma

(2012) Aruljothi Subramaniam et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma

(2012) Bing Tu et al.   CANCER LETTERS

Activation of the Notch1/STAT3/Twist signaling axis promotes gastric cancer progression

(2012) Kai-Wen Hsu et al.   CARCINOGENESIS

STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers

(2012) XIAOCHUN WANG et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

STAT proteins – Key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver

(2012) Bin Gao et al.   JOURNAL OF HEPATOLOGY

Hepatocellular carcinoma

(2012) Alejandro Forner et al.   LANCET

Targeting STAT3 inhibits growth and enhances radiosensitivity in head and neck squamous cell carcinoma

(2012) Makoto Adachi et al.   ORAL ONCOLOGY

Inhibition of Jak-STAT3 pathway enhances bufalin-induced apoptosis in colon cancer SW620 cells

(2012) Zhitu Zhu et al.   World Journal of Surgical Oncology

6-Bromoindirubin-3'-Oxime Inhibits JAK/STAT3 Signaling and Induces Apoptosis of Human Melanoma Cells

(2011) L. Liu et al.   CANCER RESEARCH

Ionizing Radiation Promotes Migration and Invasion of Cancer Cells Through Transforming Growth Factor-Beta–Mediated Epithelial–Mesenchymal Transition

(2011) Yong-Chun Zhou et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Bcl-XL and STAT3 mediate malignant actions of γ-irradiation in lung cancer cells

(2010) Jin-Nyoung Ho et al.   CANCER SCIENCE

Inhibition of STAT3 and ErbB2 Suppresses Tumor Growth, Enhances Radiosensitivity, and Induces Mitochondria-Dependent Apoptosis in Glioma Cells

(2010) Ling Gao et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Cucurbitacin I Suppressed Stem-Like Property and Enhanced Radiation-Induced Apoptosis in Head and Neck Squamous Carcinoma-Derived CD44+ALDH1+ Cells

(2010) Y.-W. Chen et al.   MOLECULAR CANCER THERAPEUTICS

Current Approach to Hepatocellular Carcinoma

(2010) Peter Abrams et al.   SURGICAL CLINICS OF NORTH AMERICA

Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005

(2009) Sean F. Altekruse et al.   JOURNAL OF CLINICAL ONCOLOGY

Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma

(2009) James A. Bonner et al.   RADIOTHERAPY AND ONCOLOGY

Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial–mesenchymal transition in ovarian carcinomas

(2008) M Colomiere et al.   BRITISH JOURNAL OF CANCER